Donor HSCs With a Preexisting ASXL1-mutation Led to the Development of FLT3-ITD Positive AML in the Donor and FLT3-ITD Negative AML in the Recipient After Unrelated Transplant

Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-017-0046-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

NOX-driven ROS Formation in Cell Transformation of FLT3-ITD-positive AML

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2016English

Mutation Analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 Patients With MDS or Secondary AML

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Copy-Neutral Loss of Heterozygosity Is Prevalent and a Late Event in the Pathogenesis of FLT3/ITD AML

Blood Cancer Journal
OncologyHematology
2014English

Dnmt3a Deletion Cooperates With the Flt3/Itd Mutation to Drive Leukemogenesis in a Murine Model

Oncotarget
Oncology
2016English

DOCK2: A Novel FLT3/ITD Leukemia Drug Target

Oncotarget
Oncology
2017English

Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

The Clinical Significance of FLT3 ITD Mutation on the Prognosis of Adult Acute Promyelocytic Leukemia

Hematology
Hematology
2017English

Overcoming AC220 Resistance of FLT3-ITD by SAR302503

Blood Cancer Journal
OncologyHematology
2013English

FLT3-ITD Compared With DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult AML Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

Turkish Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy